Walker ID - Search Results

1

Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy.

Thomson AJ, Walker ID, Greer IA. Thomson AJ, et al. Among authors: walker id. Lancet. 1998 Dec 12;352(9144):1904. doi: 10.1016/S0140-6736(05)60394-7. Lancet. 1998. PMID: 9863791 No abstract available.

2

Cost-effectiveness of screening for the factor V Leiden mutation in pregnant women.

Clark P, Twaddle S, Walker ID, Scott L, Greer IA. Clark P, et al. Among authors: walker id. Lancet. 2002 Jun 1;359(9321):1919-20. doi: 10.1016/S0140-6736(02)08740-8. Lancet. 2002. PMID: 12057557

3

Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparin.

Macklon NS, Greer IA, Reid AW, Walker ID. Macklon NS, et al. Among authors: walker id. Blood Coagul Fibrinolysis. 1995 Oct;6(7):672-5. doi: 10.1097/00001721-199510000-00008. Blood Coagul Fibrinolysis. 1995. PMID: 8562839

4

Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight.

Clark P, Walker ID, Greer I. Clark P, et al. Among authors: walker id. Lancet. 1999 Jan 23;353(9149):292-3. doi: 10.1016/S0140-6736(05)74935-7. Lancet. 1999. PMID: 9929027 No abstract available.

5

Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis.

Greer IA, Gibson JL, Young A, Johnstone J, Walker ID. Greer IA, et al. Among authors: walker id. Blood Coagul Fibrinolysis. 1999 Sep;10(6):367-73. doi: 10.1097/00001721-199909000-00007. Blood Coagul Fibrinolysis. 1999. PMID: 10493218 Clinical Trial.

6

Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series.

Rodie VA, Thomson AJ, Stewart FM, Quinn AJ, Walker ID, Greer IA. Rodie VA, et al. Among authors: walker id. BJOG. 2002 Sep;109(9):1020-4. doi: 10.1111/j.1471-0528.2002.01525.x. BJOG. 2002. PMID: 12269676

7

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

Clark P, Walker ID, Langhorne P, Crichton L, Thomson A, Greaves M, Whyte S, Greer IA; Scottish Pregnancy Intervention Study (SPIN) collaborators. Clark P, et al. Among authors: walker id. Blood. 2010 May 27;115(21):4162-7. doi: 10.1182/blood-2010-01-267252. Epub 2010 Mar 17. Blood. 2010. PMID: 20237316 Free article. Clinical Trial.

8

Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin.

Gibson JL, Ekevall K, Walker I, Greer IA. Gibson JL, et al. Br J Obstet Gynaecol. 1998 Jul;105(7):795-7. doi: 10.1111/j.1471-0528.1998.tb10212.x. Br J Obstet Gynaecol. 1998. PMID: 9692422 Clinical Trial.

9

Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy.

Ellison J, Walker ID, Greer IA. Ellison J, et al. Among authors: walker id. BJOG. 2000 Sep;107(9):1116-21. doi: 10.1111/j.1471-0528.2000.tb11110.x. BJOG. 2000. PMID: 11002955

10

Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin.

Brennand JE, Walker ID, Greer IA. Brennand JE, et al. Among authors: walker id. Acta Haematol. 1999 Mar;101(1):53-5. doi: 10.1159/000040922. Acta Haematol. 1999. PMID: 10085440 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page